LeMaitre Vascular to Present at Upcoming Investor Conferences
Get Alerts LMAT Hot Sheet
Join SI Premium – FREE
BURLINGTON, Mass., May 11, 2017 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT) announced today that it will be participating in three investor conferences.
George LeMaitre, Chairman & CEO, is scheduled to present at the East Coast IDEAS Investor Conference in Boston on Wednesday, May 17, 2017 at the Boston Park Plaza. The Company’s presentation is scheduled to begin at 10:00 AM EDT.
JJ Pellegrino, Chief Financial Officer, will participate in the Benchmark Company, LLC One-on-One Investor Conference on Thursday, June 1, 2017 at the Palmer House Hilton in Chicago, IL.
JJ Pellegrino, Chief Financial Officer, is scheduled to present at the Jefferies 2017 Global Healthcare Conference on Tuesday, June 6, 2017 at the Grand Hyatt in New York, NY. The Company’s presentation is scheduled to begin at 3:30 PM EDT.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at www.lemaitre.com.
Contact: LeMaitre Vascular, Inc. Investor Relations Steven Chehames +1-781-425-1659 [email protected]Source: LeMaitre Vascular, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Many Bright Ideas Announces Loan
- PenderFund Capital Management launches Global Small/Mid Cap Opportunities Fund
- DAVID WEEKLEY HOMES NAMES NEW CFO AND ADDS CMO TO LEADERSHIP TEAM
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Jefferies & Co, The Benchmark CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share